Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TGN-S11 |
Synonyms | |
Therapy Description |
Limited information is currently available on TGN-S11, a putative therapy for HPV-related cancers (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TGN-S11 | TGN S11|TGNS11 | Limited information is currently available on TGN-S11, a putative therapy for HPV-related cancers (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05826275 | Phase I | TGN-S11 Pembrolizumab + TGN-S11 | Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer | Recruiting | USA | 0 |